Back to STATE STREET CORP STATE STREET CORP

ELVNELVN
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in ENLIVEN THERAPEUTICS INC

STATE STREET CORP holds 1.2M shares of ELVN (ENLIVEN THERAPEUTICS INC), worth $61.6M as of 2026-Q2. The position was increased (+11.2% shares). ELVN represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$61.6M

Current Shares

1.2M

Total Value Change

+$42.5M

Total Shares Change

+467,672

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.2M
+11.2%
$61.6M0.0%$50.75
33
2026-Q1
Increased
1.1M
+3.6%
$42.8M0.0%$28.75
30
2025-Q4
Increased
1.1M
+9.1%
$16.2M0.0%$15.55
31
2025-Q3
Increased
965,137
+18.2%
$19.8M0.0%$20.30
33
2025-Q2
Increased
816,242
+4.5%
$16.4M0.0%$20.68
30
2025-Q1
Decreased
780,902
-2.6%
$15.4M0.0%$21.07
0
2024-Q4
Increased
801,832
+7.5%
$18M0.0%$22.39
30
2024-Q3
Increased
745,944
+2.9%
$19.1M0.0%$24.13
29

Other major holders of ELVN: FMR LLC, Polar Capital Holdings Plc, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used